How much funding has Elligo Health Research raised?

Elligo Health Research has raised $236.0M in total funding, most recently a Series E round.

Who are Elligo Health Research's investors?

Elligo Health Research's investors include Shiv Chaudhary, Horizon Technology Finance, Morgan Stanley, Ally Bridge Group, Cerner Corporation, Piper Jaffray Merchant Banking.

When was Elligo Health Research founded?

Elligo Health Research was founded in 2016.

Where is Elligo Health Research headquartered?

Elligo Health Research is headquartered in Austin, Texas, United States.

What industry is Elligo Health Research in?

Elligo Health Research operates in Biotech, Healthcare, Life Sciences, Digital Health.

How many employees does Elligo Health Research have?

Elligo Health Research has 201-500 employees.

Elligo Health Research

One Partner for Every Clinical Trial Solution | Elligo

Austin, United States · Founded 2016 · $236.0M raised

Headquarters: Austin, Texas
Employees: 201–500
Founded: 2016
Business Model: B2B

Website: elligohealthresearch.com
Total Funding: $236.0M
Last Round: $135.0M Series ESep 2021
Rounds: 5

About

Elligo Health Research is a first-of-its-kind Integrated Research Organization (IRO) that accelerates clinical trials by embedding research directly into real-world healthcare settings, leveraging EHR data, a network of 400+ research-ready sites, and 70K+ site network patients to connect sponsors and CROs with diverse patient populations. The company offers end-to-end trial support including decentralized, hybrid, and traditional studies across 38+ countries with a 93% post-randomization retention rate.

Summary

Elligo Health Research is a Biotech company based in Austin, United States, founded in 2016. It has raised $236.0M in total across 5 rounds, most recently a $135.0M Series E round in Sep 2021. Investors include Shiv Chaudhary, Horizon Technology Finance and Morgan Stanley.

LinkedIn X (Twitter)